This company has been marked as potentially delisted and may not be actively trading. NASDAQ:SBOT Stellar Biotechnologies (SBOT) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisCompetitorsTrendsBuy This Stock About Stellar Biotechnologies Stock (NASDAQ:SBOT) 30 days 90 days 365 days Advanced Chart Remove Ads Get SBOT alerts:Sign Up Key Stats Today's Range$5.27▼$5.5750-Day Range$4.44▼$298,098.0052-Week Range$0.75▼$3.25Volume3.57 million shsAverage Volume2.95 million shsMarket Capitalization$28.84 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewStellar Biotechnologies, Inc., a biotechnology company, engages in the aquaculture, research and development, manufacture, and commercialization of keyhole limpet hemocyanin (KLH) protein in Europe, North America, and Asia. The company offers KLH, an immune-stimulating protein used in the production of various immunotherapies; and as a carrier molecule or finished injectable product in the immunodiagnostic market. It provides its KLH protein under the Stellar KLH brand. The company's products include Stellar KLH protein in various grades, formulations, custom configurations, and fill finishes for drug development and research applications, as well as KLH-based in vitro diagnostic kits for research and preclinical use. Its customers and partners comprise biotechnology and pharmaceutical companies, academic institutions, clinical research organizations, and research centers. Stellar Biotechnologies, Inc. is based in Port Hueneme, California.Read More… Remove Ads Receive SBOT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Stellar Biotechnologies and its competitors with MarketBeat's FREE daily newsletter. Email Address SBOT Stock News HeadlinesServe Robotics ties up with Alphabet's unit for drone deliveries, launching pilot in TexasOctober 1, 2024 | reuters.comAre robots the future of food delivery? Serve Robotics thinks soMay 5, 2024 | finance.yahoo.comTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionApril 4, 2025 | Crypto 101 Media (Ad)Uber, Nvidia-backed Serve Robotics hits public markets with $40M splashApril 18, 2024 | techcrunch.comZach Wilson’s stellar day at Jets camp includes long touchdown throwJuly 30, 2023 | nypost.comCaterpillar's Stellar Move To Attract High-Quality EmployeesJune 7, 2023 | forbes.comStellar Bancorp, Inc. Declares Quarterly DividendFebruary 26, 2023 | benzinga.comO's closer Felix Bautista goes on DL ending stellar rookie yearOctober 5, 2022 | cbsnews.comSee More Headlines SBOT Stock Analysis - Frequently Asked Questions How were Stellar Biotechnologies' earnings last quarter? Stellar Biotechnologies Inc (NASDAQ:SBOT) issued its quarterly earnings data on Wednesday, May, 8th. The biotechnology company reported ($0.31) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.26) by $0.05. The biotechnology company earned $0.12 million during the quarter, compared to analysts' expectations of $0.11 million. Stellar Biotechnologies had a negative trailing twelve-month return on equity of 51.12% and a negative net margin of 1,782.64%. When did Stellar Biotechnologies' stock split? Shares of Stellar Biotechnologies reverse split on the morning of Monday, May 7th 2018. The 1-7 reverse split was announced on Friday, April 27th 2018. The number of shares owned by shareholders was adjusted after the market closes on Friday, May 4th 2018. An investor that had 100 shares of stock prior to the reverse split would have 14 shares after the split. What other stocks do shareholders of Stellar Biotechnologies own? Based on aggregate information from My MarketBeat watchlists, some other companies that Stellar Biotechnologies investors own include NightHawk Biosciences (NHWK), NexGen Energy (NXE), XOMA (XOMA), Anavex Life Sciences (AVXL), EyePoint Pharmaceuticals (EYPT), OPKO Health (OPK) and Rigel Pharmaceuticals (RIGL). Company Calendar Last Earnings5/08/2019Today4/04/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical Preparations Sub-IndustryN/A Current SymbolNASDAQ:SBOT CIK1540159 Webwww.stellarbiotechnologies.com Phone805-488-2800FaxN/AEmployees25Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($1.76) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-5,030,000.00 Net Margins-1,782.64% Pretax MarginN/A Return on Equity-51.12% Return on Assets-48.37% Debt Debt-to-Equity RatioN/A Current Ratio9.24 Quick Ratio8.96 Sales & Book Value Annual Sales$210,000.00 Price / Sales137.31 Cash FlowN/A Price / Cash FlowN/A Book Value$2.12 per share Price / Book2.55Miscellaneous Outstanding Shares5,330,000Free FloatN/AMarket Cap$28.84 million OptionableNot Optionable BetaN/A These 7 Stocks Will Be Magnificent in 2025Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free Report This page (NASDAQ:SBOT) was last updated on 4/4/2025 by MarketBeat.com Staff From Our PartnersTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredYour Retirement Is Caught in the CrossfireWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredTrump’s Great Society Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Stellar Biotechnologies Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Stellar Biotechnologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.